Results 131 to 140 of about 9,143 (202)
Abstract In HIV‐ and tuberculosis (TB)‐endemic regions, lymphoma diagnosis is often delayed because symptoms can overlap with TB, and access to biopsy and specialized pathology is limited. To address this, we developed and internally evaluated the Access to Diagnosis using Liquid Biopsy (ADLiB) platform—a plasma cell‐free DNA (cfDNA)‐based approach ...
Katherine Antel +21 more
wiley +1 more source
Introduction Human papillomavirus type 16 (HPV16) E6 antibodies may be an early biomarker of anal cancer. We cross-sectionally evaluated when in the course of anal disease, HPV16 antibodies are induced.
Krystle A. Lang Kuhs PhD +9 more
doaj +1 more source
Assessment of correlation between pSTAT3 with HPV16 viral load and E2: E6 Ratio in HPV16-positive cervical tissues (n = 130).
Sutapa Mahata (434793) +7 more
core +1 more source
Human Papillomavirus: Update in Bridging Basic Science to Clinical and Public Health Innovations
ABSTRACT Human papillomavirus (HPV), a non‐enveloped, double‐strand DNA viral pathogen, is intricately linked with the onset of various cancers, including cervical cancer and head and neck cancers. The present paper delves into HPV's ancient recognition and significant milestones such as the discovery of its role in oncogenesis and the development of ...
Fatemeh Beygnejad +4 more
wiley +1 more source
High-risk human papillomaviruses (HR HPVs) are responsible for around 5% of the world’s cancer burden. Activation and interaction with the host DNA damage response (DDR) promote the HPV16 life cycle.
Claire D. James +12 more
doaj +1 more source
Human papillomaviruses, mainly type 16 (HPV16), are responsible for cervical intraepithelial neoplasia, which can lead, in association with other factors, to cervical cancer.
Nardelli-Haefliger, Denise +11 more
core +1 more source
Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives
ABSTRACT Oncogenic viral and bacterial infections constitute a significant portion of the global cancer burden, accounting for up to 15% of cases, particularly in low‐ and middle‐income countries. Prophylactic vaccination thus appears to be the most effective tool for preventing these preventable cancers, especially those linked to human papillomavirus
Christian Tague +5 more
wiley +1 more source
Detection of HPV16 L2-specific antibodies in Balb/c mice vaccinated with AAVLP(HPV16/31L2).
Mice were immunized with low dose of AAVLP(HPV16/31L2) particles either twice (LD+M 2x) or three times (LD+M 3x) i.m. together with montanide ISA51 as an adjuvant.
Uwe Michaelis (318085) +13 more
core +1 more source
What's new? Hypoxic regions and inflammatory Th17 cells in the tumor environment are both associated with poor prognosis in cervical cancer. However, synergistic mechanisms between hypoxia and Th17 cells remain elusive. This study demonstrated Th17–hypoxia‐driven mechanisms underlying cervical cancer progression.
Selina Gies +12 more
wiley +1 more source
Characterization of patient-derived HPV16 E6 and E7 variant alleles
Human papillomavirus type 16 (HPV16) is the most prevalent carcinogenic HPV type. Many HPV16 sequence variants have been described, some of which cause protein-coding mutations.
Miranda Grace +7 more
doaj +1 more source

